Norges Bank’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Norges Bank’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-34,313	Closed	-$229K	–	2190
2017 Q2	$229K	Hold	34,313	–	–	﹤0.01%	2108
2017 Q1	$133K	Sell	34,313 -1,000	-3%	-$3.51K	﹤0.01%	2131
2016 Q4	$130K	Hold	35,313	–	–	﹤0.01%	2142
2016 Q3	$140K	Hold	35,313	–	–	﹤0.01%	2137
2016 Q2	$164K	Hold	35,313	–	–	﹤0.01%	2157
2016 Q1	$116K	Hold	35,313	–	–	﹤0.01%	2178
2015 Q4	$120K	Hold	35,313	–	–	﹤0.01%	2217
2015 Q3	$129K	Sell	35,313 -387	-1%	-$1.76K	﹤0.01%	2251
2015 Q2	$177K	Sell	35,700 -9,300	-21%	-$64.4K	﹤0.01%	2233
2015 Q1	$361K	Buy	+45,000	New	+$426K	﹤0.01%	2227

Norges Bank's NVET Position: Q3 2017 in Review

Norges Bank sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 34,313 shares — an estimated $229K sold.

Norges Bank first reported a position in NVET in Q1 2015 and held it in 10 quarters. The position peaked at $361K in Q1 2015. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Norges Bank reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Norges Bank sold 34,313 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $229K.
Norges Bank first reported a position in Nexvet Biopharma plc Ordinary Shares in Q1 2015 and held it in 10 quarters.
Norges Bank's Nexvet Biopharma plc Ordinary Shares position peaked at $361K in Q1 2015.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Norges Bank's 13F filing for Q3 2017, filed 7 Nov 2017.